JP2020523282A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020523282A5 JP2020523282A5 JP2019552978A JP2019552978A JP2020523282A5 JP 2020523282 A5 JP2020523282 A5 JP 2020523282A5 JP 2019552978 A JP2019552978 A JP 2019552978A JP 2019552978 A JP2019552978 A JP 2019552978A JP 2020523282 A5 JP2020523282 A5 JP 2020523282A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- aryl
- cycloheteroalkenyl
- cycloheteroalkyl
- arylalkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 Cc1n[n]cc1*CNc1nc2cc(S)ccc2[s]1 Chemical compound Cc1n[n]cc1*CNc1nc2cc(S)ccc2[s]1 0.000 description 39
- XYEKVCDZBKLYKQ-UHFFFAOYSA-N CC(C)c(cc1)cc2c1[nH]nc2 Chemical compound CC(C)c(cc1)cc2c1[nH]nc2 XYEKVCDZBKLYKQ-UHFFFAOYSA-N 0.000 description 1
- LGMLMQXUCJTHGH-UHFFFAOYSA-N CC(C)c1c[nH]nc1C(F)(F)F Chemical compound CC(C)c1c[nH]nc1C(F)(F)F LGMLMQXUCJTHGH-UHFFFAOYSA-N 0.000 description 1
- ASIFVGBIFBHPJO-KGKSHYRASA-N CCN(CC)CC(c(c1c(cc2)nc(/C(/C(C)=N)=C/N)c3c1CCCC3)c2NN)=C Chemical compound CCN(CC)CC(c(c1c(cc2)nc(/C(/C(C)=N)=C/N)c3c1CCCC3)c2NN)=C ASIFVGBIFBHPJO-KGKSHYRASA-N 0.000 description 1
- RNSHSZQPQQPZMD-UHFFFAOYSA-O CCc1c(C(C(C=C2)[NH3+])C=N)c2nc(C(CC2)=Cc3c2[nH]nc3N(C)CCO)c1CC=C Chemical compound CCc1c(C(C(C=C2)[NH3+])C=N)c2nc(C(CC2)=Cc3c2[nH]nc3N(C)CCO)c1CC=C RNSHSZQPQQPZMD-UHFFFAOYSA-O 0.000 description 1
- KVSVMTWPPWJVEM-UHFFFAOYSA-N CN(C)C(c1n[nH]cc1-c1c(CCCC2)c2c(c2c(cc3)[nH][n]c2)c3c1)=O Chemical compound CN(C)C(c1n[nH]cc1-c1c(CCCC2)c2c(c2c(cc3)[nH][n]c2)c3c1)=O KVSVMTWPPWJVEM-UHFFFAOYSA-N 0.000 description 1
- ARVUNNKSHDGHPF-UHFFFAOYSA-O CN(CCO)c1c[nH]c(cc2)c1c1c2nc(C(C(C2CC2)=N)=C[NH3+])c2c1CCCC2 Chemical compound CN(CCO)c1c[nH]c(cc2)c1c1c2nc(C(C(C2CC2)=N)=C[NH3+])c2c1CCCC2 ARVUNNKSHDGHPF-UHFFFAOYSA-O 0.000 description 1
- GJOOCAXPERKNMN-UHFFFAOYSA-N Cc(c(F)c1)ccc1O Chemical compound Cc(c(F)c1)ccc1O GJOOCAXPERKNMN-UHFFFAOYSA-N 0.000 description 1
- AHAMWENZZWAOED-UHFFFAOYSA-N Cc1c(c(CCC(C2)C(Nc3ccc(C=N)cc3)=O)c2c(C(CCC2)=CC=C2O)n2)c2ccc1NN Chemical compound Cc1c(c(CCC(C2)C(Nc3ccc(C=N)cc3)=O)c2c(C(CCC2)=CC=C2O)n2)c2ccc1NN AHAMWENZZWAOED-UHFFFAOYSA-N 0.000 description 1
- QJDSMZPLJZUCEO-UHFFFAOYSA-O NCC(c(c1c(cc2)nc(-c3c[nH]nc3C(F)(F)F)c3c1CCCC3)c2[NH3+])=N Chemical compound NCC(c(c1c(cc2)nc(-c3c[nH]nc3C(F)(F)F)c3c1CCCC3)c2[NH3+])=N QJDSMZPLJZUCEO-UHFFFAOYSA-O 0.000 description 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022027439A JP7837179B2 (ja) | 2017-03-29 | 2022-02-25 | キナーゼネットワークの阻害剤およびその使用 |
| JP2022150644A JP7668254B2 (ja) | 2017-03-29 | 2022-09-21 | キナーゼネットワークの阻害剤およびその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762478069P | 2017-03-29 | 2017-03-29 | |
| US62/478,069 | 2017-03-29 | ||
| US201862616643P | 2018-01-12 | 2018-01-12 | |
| US62/616,643 | 2018-01-12 | ||
| PCT/US2018/024991 WO2018183586A1 (en) | 2017-03-29 | 2018-03-29 | Inhibitors of kinase networks and uses thereof |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022027439A Division JP7837179B2 (ja) | 2017-03-29 | 2022-02-25 | キナーゼネットワークの阻害剤およびその使用 |
| JP2022150644A Division JP7668254B2 (ja) | 2017-03-29 | 2022-09-21 | キナーゼネットワークの阻害剤およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020523282A JP2020523282A (ja) | 2020-08-06 |
| JP2020523282A5 true JP2020523282A5 (enExample) | 2020-09-17 |
| JP7788208B2 JP7788208B2 (ja) | 2025-12-18 |
Family
ID=63677063
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019552978A Active JP7788208B2 (ja) | 2017-03-29 | 2018-03-29 | キナーゼネットワークの阻害剤およびその使用 |
| JP2022027439A Active JP7837179B2 (ja) | 2017-03-29 | 2022-02-25 | キナーゼネットワークの阻害剤およびその使用 |
| JP2022150644A Active JP7668254B2 (ja) | 2017-03-29 | 2022-09-21 | キナーゼネットワークの阻害剤およびその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022027439A Active JP7837179B2 (ja) | 2017-03-29 | 2022-02-25 | キナーゼネットワークの阻害剤およびその使用 |
| JP2022150644A Active JP7668254B2 (ja) | 2017-03-29 | 2022-09-21 | キナーゼネットワークの阻害剤およびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US11040973B2 (enExample) |
| EP (2) | EP4233859A1 (enExample) |
| JP (3) | JP7788208B2 (enExample) |
| CN (1) | CN110662536B (enExample) |
| CA (1) | CA3056641A1 (enExample) |
| WO (1) | WO2018183586A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7788208B2 (ja) * | 2017-03-29 | 2025-12-18 | パデュー リサーチ ファウンデイション | キナーゼネットワークの阻害剤およびその使用 |
| CA3087972C (en) | 2018-01-18 | 2023-01-10 | Array Biopharma Inc. | Substituted pyrazolyl[4,3-c]pyridinecompounds as ret kinase inhibitors |
| EP3740491A1 (en) | 2018-01-18 | 2020-11-25 | Array Biopharma, Inc. | Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors |
| US20220017908A1 (en) * | 2018-11-20 | 2022-01-20 | Fulcrum Therapeutics, Inc. | Compositions and methods for increasing fetal hemoglobin and treating sickle cell disease |
| AU2019396360A1 (en) | 2018-12-11 | 2021-05-27 | Theravance Biopharma R&D Ip, Llc | Naphthyridine and quinoline derivatives useful as ALK5 inhibitors |
| WO2021061823A1 (en) * | 2019-09-23 | 2021-04-01 | Boragen, Inc. | Chemical compounds |
| IL293084A (en) | 2019-11-22 | 2022-07-01 | Theravance Biopharma R& D Ip Llc | Substituted 1,5-naphthyridines or quinolines as alk5 inhibitors |
| CN113214294A (zh) * | 2020-06-10 | 2021-08-06 | 深圳铂立健医药有限公司 | 三环化合物、药物组合物及其应用 |
| WO2022006365A2 (en) * | 2020-07-02 | 2022-01-06 | Purdue Research Foundation | Tetrahydro-3h-pyrazolo quinolone and tetrahydro-3h-pyrrolo[3,2-f]quinoline-containing compounds and uses thereof |
| KR20250004773A (ko) * | 2022-04-20 | 2025-01-08 | 상하이 지멍 바이오파마 아이엔씨 | Rho 관련 단백질 키나아제 억제제 및 이의 제조와 응용 |
| CN117186002A (zh) * | 2022-05-31 | 2023-12-08 | 江苏亚虹医药科技股份有限公司 | 7-氰基-8-羟基喹啉衍生物、其制备方法及其医药用途 |
| EP4532471A4 (en) * | 2022-06-02 | 2026-05-06 | Purdue Research Foundation | 4-(3H-PYRAZOLO[4,3-F]QUINOLIN-7-YL)-N-(2-(DIMETHYLAMINO)ETHYL)BENZAMIDE OR HYDROXAMIC ACID COMPOUNDS, COMPOSITIONS AND METHODS OF USE |
| JP2026511085A (ja) * | 2023-03-24 | 2026-04-10 | パーデュー・リサーチ・ファウンデイション | ＳＴＩＮＧアンタゴニストとしての３Ｈ－ピラゾロ［４，３－ｆ］キノリン系化合物 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3947434A (en) * | 1973-06-06 | 1976-03-30 | Morton-Norwich Products, Inc. | 9-(P-phenylazoanilino)-7-methyl-1H-imidazo[4,5-f]quinolines |
| CA1263378A (en) * | 1985-01-08 | 1989-11-28 | Robert James Alaimo | Imidazo¬4,5-f|quinolines useful as immunomodulating agents |
| JP3406600B2 (ja) * | 1992-05-01 | 2003-05-12 | 興和株式会社 | キノリン誘導体又はその塩，及びこれを含有する心疾患治療剤 |
| US6228362B1 (en) * | 1992-08-21 | 2001-05-08 | Immunomedics, Inc. | Boron neutron capture therapy using pre-targeting methods |
| US7405320B2 (en) | 1998-06-22 | 2008-07-29 | Immunomedics, Inc. | Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| NZ513639A (en) * | 1999-04-15 | 2004-02-27 | Bristol Myers Squibb Co | Cyclic protein tyrosine kinase inhibitors |
| US20050080260A1 (en) * | 2003-04-22 | 2005-04-14 | Mills Randell L. | Preparation of prodrugs for selective drug delivery |
| US20050043233A1 (en) * | 2003-04-29 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis |
| US20060281771A1 (en) * | 2005-06-10 | 2006-12-14 | Baumann Christian A | Synergistic modulation of flt3 kinase using aminoquinoline and aminoquinazoline kinase modulators |
| BRPI0609191B8 (pt) * | 2005-06-17 | 2021-05-25 | Ligand Pharm Inc | métodos e compostos moduladores de receptor de androgênio |
| US20090227571A1 (en) * | 2005-07-01 | 2009-09-10 | Ligand Pharmaceuticals Incorporated | Androgen Receptor Modulator Compounds and Methods |
| EP2487175A1 (en) * | 2009-10-06 | 2012-08-15 | Kyowa Hakko Kirin Co., Ltd. | Pharmaceutical product containing aromatic heterocyclic compound |
| BR112013011737A2 (pt) * | 2010-11-15 | 2016-08-09 | Univ Leuven Kath | composto, uso de um composto composição farmacêutica, e, método de tratamento ou prevenção de uma infecção por hiv |
| EP3453710B1 (en) * | 2014-09-17 | 2022-09-21 | Celgene Quanticel Research, Inc. | Histone demethylase inhibitors |
| WO2016112284A1 (en) * | 2015-01-09 | 2016-07-14 | Genentech, Inc. | (piperidin-3-yl)(naphthalen-2-yl)methanone derivatives and related compounds as inhibitors of the histone demethylase kdm2b for the treatment of cancer |
| JP7788208B2 (ja) * | 2017-03-29 | 2025-12-18 | パデュー リサーチ ファウンデイション | キナーゼネットワークの阻害剤およびその使用 |
-
2018
- 2018-03-29 JP JP2019552978A patent/JP7788208B2/ja active Active
- 2018-03-29 US US16/499,133 patent/US11040973B2/en active Active
- 2018-03-29 EP EP23176745.0A patent/EP4233859A1/en active Pending
- 2018-03-29 CN CN201880034786.5A patent/CN110662536B/zh active Active
- 2018-03-29 EP EP18776719.9A patent/EP3600287B1/en active Active
- 2018-03-29 CA CA3056641A patent/CA3056641A1/en active Pending
- 2018-03-29 WO PCT/US2018/024991 patent/WO2018183586A1/en not_active Ceased
-
2021
- 2021-04-29 US US17/243,629 patent/US11891391B2/en active Active
-
2022
- 2022-02-25 JP JP2022027439A patent/JP7837179B2/ja active Active
- 2022-09-21 JP JP2022150644A patent/JP7668254B2/ja active Active
-
2023
- 2023-12-21 US US18/392,204 patent/US12384782B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2021251689B2 (en) | Inhalation formulations of 1'-cyano substituted carbanucleoside analogs | |
| ES2665539T3 (es) | Derivados de benzamida para inhibir la actividad de ABL1, ABL2 y BCR-ABL1 | |
| JP2020504733A (ja) | テノホビルの抗ウイルス性脂肪族エステルプロドラッグ | |
| TW200844108A (en) | Compounds and pharmaceutical compositions for the treatment of liver disorders | |
| IL200240A (en) | A 6-Amino-8-Hydroxy-Purine-9-Ilbenzyl Pharmaceutical Compound Conjugated with Diolauylphosphatidyl Ethanolamine | |
| JP2013531067A (ja) | 疾病及び状態の処置及び予防のためのフルオロ置換オメガ−カルボキシアリールジフェニル尿素を用いた組み合わせ薬 | |
| WO2013052263A2 (en) | Antifungal compounds | |
| CN103265543A (zh) | 抑制瞬时受体电位离子通道trpa1 | |
| RU2008145714A (ru) | Пуриновые производные в качестве активатора аденозинового рецептора | |
| Durham et al. | Spray dried aerosol particles of pyrazinoic acid salts for tuberculosis therapy | |
| US20190031730A1 (en) | Formulation of mk2 inhibitor peptides | |
| NO152445B (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 9-(hydroksylalkyl)puriner | |
| JP2022551477A (ja) | ４’－ハロゲン含有ヌクレオチドおよびヌクレオシド治療組成物ならびにそれらに関連する使用 | |
| CN110603038A (zh) | 雷帕霉素类似物 | |
| AU2015292050B2 (en) | New polycrystalline form of tenofovir prodrug, and preparation method and application therefor | |
| KR101838764B1 (ko) | (ｅ)-4-카복시스티릴-4-클로로벤질설폰의 개선된 안정한 수성 제형 | |
| CN102827146B (zh) | 一种氟喹诺酮醛缩异烟腙及其制备方法和应用 | |
| IL291574B2 (en) | Methods for using 5-Adenosine Diphosphate Ribose (ADPR) | |
| EP3174545A1 (de) | Effiziente hemmung von hsp27 | |
| CN105968134B (zh) | 一种Keggin结构杂多酸含磷有机盐类化合物、制备方法和应用 | |
| WO2019228319A1 (zh) | 基于肠道mct1载体蛋白设计的前药及其制备方法 | |
| US20180305330A1 (en) | Materials and method for inhibiting replication protein a and uses thereof | |
| JP2016508957A (ja) | カンジダ等の病原微生物による疾患用の医薬組成物 | |
| EP4357340A1 (en) | Salt of selective fgfr4 inhibitor, and preparation method therefor and application thereof | |
| CN113329753B (zh) | 用于预防和治疗革兰氏阴性细菌感染、污染和污垢的新型嘧啶衍生物 |